AML WITH FLT3 MUTATION

Clinical trials for AML WITH FLT3 MUTATION explained in plain language.

Never miss a new study

Get alerted when new AML WITH FLT3 MUTATION trials appear

Sign up with your email to follow new studies for AML WITH FLT3 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for leukemia patients who run out of options

Disease control Ongoing

This study tested whether a new targeted pill (gilteritinib) works better than standard chemotherapy for adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to first treatment. The goal was to see if the new drug helps patients live long…

Matched conditions: AML WITH FLT3 MUTATION

Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

AML WITH FLT3 MUTATION

Get alerted when new AML WITH FLT3 MUTATION trials appear

New hope for leukemia patients who run out of options